export default function ThymulinOverviewPanel() {
  return (
    <div className="reta-overview">

      <p className="reta-overview__opener">
        Thymulin is a nine-amino acid peptide produced by your thymus — the gland that educates immune cells and shrinks dramatically as you age. It only works when bound to zinc; without zinc, it&rsquo;s biologically inert. As a research compound with no FDA approval and sparse human data, it sits at the edge of what can be honestly said about any peptide. The most important practical insight: for many people with impaired thymic signaling, the problem is zinc deficiency, not thymulin deficiency.
      </p>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 1</div>
        <h3 className="reta-overview__profile-heading">The Average Person &mdash; Curious About Immune Health</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I keep reading that our immune system gets worse as we age because the thymus shrinks. Is thymulin a way to address that, or is it too experimental to bother with?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>The thymic involution story is real and documented</strong><br />The thymus does genuinely shrink with age — dramatically so after puberty — and circulating thymulin levels fall in parallel. The connection between declining thymic output and aging immune systems is well-established biology. The idea that supplementing with the thymus&rsquo;s own signaling molecule might partially restore youthful immune function has an intuitive appeal grounded in real science.</li>
          <li><strong>The zinc connection is practically actionable</strong><br />Here&rsquo;s the thing most people don&rsquo;t know: thymulin is biologically inactive without zinc. Studies have shown that zinc deficiency reduces detectable thymulin activity, and restoring zinc status in deficient people restores it. If your immune function is impaired partly because your thymulin can&rsquo;t bind zinc, addressing zinc deficiency is a directly actionable, low-risk intervention.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">There are no published Phase 2 or Phase 3 human trials for injected thymulin as an immune compound as of early 2026. The animal model evidence is interesting — T cell differentiation effects and even some anti-pain signals in rodents — but translating that to human dosing, safety, and expected effects involves a significant evidence gap. For most people asking about immune health, zinc status and Thymosin Alpha-1 (which has actual human clinical data in immune contexts) are better-evidenced starting points. Net: fascinating biology, but too thin on human evidence for anything beyond curiosity at this stage.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 2</div>
        <h3 className="reta-overview__profile-heading">The Athlete &mdash; Immune Health Under Training Load</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I&rsquo;ve already looked at Thymosin Alpha-1 for immune support. How does thymulin compare? Is it more targeted or just more experimental?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>Thymulin acts specifically at the T cell maturation stage</strong><br />Where Thymosin Alpha-1 broadly supports T cell competence and dendritic cell function, thymulin works specifically on the earlier stage — the education and maturation of T cells in the thymus itself. For an athlete thinking about immune architecture at a systems level, that upstream specificity is an interesting angle.</li>
          <li><strong>The antinociceptive effects from rodent research are intriguing</strong><br />Animal studies show thymulin peptide analogs have pain-reducing effects through peripheral immune mechanisms — not through the central nervous system directly. For athletes dealing with persistent training-related pain and inflammation, a compound that works through immune pathways rather than opioid pathways is conceptually interesting, even if the human data is absent.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">Thymulin is strictly more experimental than Thymosin Alpha-1 — the clinical evidence gap is significant. Thymosin Alpha-1 has approved status in 35 countries and human trial data; thymulin does not. Any athlete choosing thymulin over Thymosin Alpha-1 is choosing the less evidence-supported option for essentially the same conceptual goal. The zinc dependency means that thymulin activity is contingent on zinc status — anyone who is zinc deficient (common in endurance athletes who sweat heavily) may not get the expected response without concurrent zinc optimization. Net: more experimental, less evidence, the same use case addressed better by Thymosin Alpha-1.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 3</div>
        <h3 className="reta-overview__profile-heading">The Biohacker &mdash; Thymic Biology and Immune Aging</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;Thymulin is the thymus&rsquo;s own maturation hormone. The zinc-dependent activation is a fascinating regulatory mechanism. What does the biology actually say about what exogenous thymulin could do for immune aging?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>The zinc-thymulin axis is one of the most elegant regulatory mechanisms in immune biology</strong><br />Thymulin binds zinc in a precise 1:1 ratio, and only the zinc-bound form has biological activity. This means the immune maturation signal from the thymus is conditionally gated on zinc availability — a mineral that declines with age and poor diet. Understanding this regulatory axis offers both a mechanistic insight and a practical intervention point that doesn&rsquo;t require a peptide at all.</li>
          <li><strong>The thymus as an immune education organ is underappreciated in longevity discussions</strong><br />Most longevity immune discussions focus on downstream effector cells. Thymulin works at the teacher level — the education infrastructure that determines how well your immune cells know themselves from pathogens and tumor cells. Restoring that upstream function, even partially, could have broader immune system effects than any downstream intervention.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">The human evidence for exogenous thymulin administration is confined to early-phase feasibility work — no controlled trials have characterized the dose-response, durability, or safety profile in humans. The rodent antinociceptive data has generated interest in thymulin peptide analogs for pain, but those analogs are distinct from thymulin itself. The immunosenescence hypothesis is compelling but unproven for thymulin specifically — the connection between declining thymulin levels and declining immune function is correlational, and whether restoring thymulin levels reverses immune aging meaningfully in humans is not established. The most evidence-supported version of the zinc-thymulin insight is to test and correct zinc deficiency, not to add exogenous thymulin on top. Net: mechanistically rich with genuinely interesting biology, but practically premature as a human intervention.</p>
      </div>

      <div className="reta-overview__bottom">
        <p className="reta-overview__bottom-heading">The honest bottom line</p>
        <div className="reta-overview__bottom-cols">
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What Thymulin is NOT</p>
            <ul className="reta-overview__bottom-list">
              <li>Proven to work when injected exogenously — no Phase 2 or 3 human trials for immune support</li>
              <li>Biologically active without zinc — the zinc-bound form is the active molecule; zinc deficiency negates thymulin activity</li>
              <li>More evidence-supported than Thymosin Alpha-1 for immune goals — it&rsquo;s strictly less studied in humans</li>
              <li>FDA-approved or approved anywhere — a research compound with no regulatory clinical status</li>
              <li>A standalone immune intervention — zinc deficiency is the first thing to evaluate and correct</li>
            </ul>
          </div>
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What makes it interesting</p>
            <ul className="reta-overview__bottom-list">
              <li>The zinc-dependency is a unique regulatory mechanism not seen in other immune peptides</li>
              <li>Works at the T cell maturation stage — upstream of the immune response, not just downstream effectors</li>
              <li>Rodent data shows antinociceptive (pain-reducing) effects through peripheral immune mechanisms — a novel angle</li>
              <li>The thymic involution hypothesis directly addresses one of the most documented features of immune aging</li>
              <li>The zinc-thymulin insight has an immediately actionable consequence: test and optimize zinc status first</li>
            </ul>
          </div>
        </div>
      </div>

    </div>
  );
}
